An analysis of the mechanism by which cetiedil inhibits sickling
- PMID: 11860149
- DOI: 10.1016/s0024-3205(01)01477-1
An analysis of the mechanism by which cetiedil inhibits sickling
Abstract
A study has been carried out into the effects of cetiedil on the activities of Na+, K+ and Ca2+, Mg2+-ATPases of the normal human erythrocyte membrane. In general, cetiedil inhibits both ATPases activities but with characteristic inhibition profiles and varying degrees of efficacy. The activities were inhibited non-competitively at the cetiedil concentration which caused 50% inhibition of each enzyme. In addition, the effects of cetiedil on the transport of K+ and phosphate ions across the membrane were monitored and compared. Cetiedil was found to stimulate K+ release and to inhibit phosphate uptake. At low concentrations, both processes were concentration dependent. Stimulation of K+ efflux reached a plateau at a concentration of 1.2 mM. The antisickling effect of cetiedil is explained mainly in the light of the changes it induces in the activities of membrane-bound ATPases and the permeability properties of the erythrocyte membrane to cations and anions.
Similar articles
-
Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.Blood Cells. 1982;8(2):283-8. Blood Cells. 1982. PMID: 7159752
-
An explanation for the efficacy of procaine in the treatment of sickle cell anaemia.Int J Biochem Cell Biol. 2005 Apr;37(4):835-41. doi: 10.1016/j.biocel.2004.09.012. Int J Biochem Cell Biol. 2005. PMID: 15694842
-
Inhibition of erythrocyte calcium transport by cetiedil.Pharmacology. 1988;36(1):44-51. doi: 10.1159/000138345. Pharmacology. 1988. PMID: 2829242
-
Clinical Pharmacology for Pediatricians. II. Antisickling agents, with special reference to new vasoerythroactive drugs.J Clin Pharmacol. 1982 Jan;22(1):1-13. doi: 10.1002/j.1552-4604.1982.tb05701.x. J Clin Pharmacol. 1982. PMID: 7037870 Review. No abstract available.
-
Membrane modifiers in sickle cell disease.Ann N Y Acad Sci. 1989;565:247-61. doi: 10.1111/j.1749-6632.1989.tb24173.x. Ann N Y Acad Sci. 1989. PMID: 2672964 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous